These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The long-term effects of in utero exposures--the DES story. Goodman A; Schorge J; Greene MF N Engl J Med; 2011 Jun; 364(22):2083-4. PubMed ID: 21506735 [No Abstract] [Full Text] [Related]
3. The Diethylstilbestrol Legacy: A Powerful Case Against Intervention in Uncomplicated Pregnancy. Troisi R; Hatch EE; Titus L Pediatrics; 2016 Nov; 138(Suppl 1):S42-S44. PubMed ID: 27940976 [No Abstract] [Full Text] [Related]
4. Vaginal cancer: an iatrogenic disease? Weiss K Int J Health Serv; 1975; 5(2):235-51. PubMed ID: 1181297 [TBL] [Abstract][Full Text] [Related]
5. Epidemiological studies of the effects of diethylstilboestrol. Vessey MP IARC Sci Publ; 1989; (96):335-48. PubMed ID: 2680951 [TBL] [Abstract][Full Text] [Related]
6. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals. Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019 [TBL] [Abstract][Full Text] [Related]
7. Endobronchial clear cell adenocarcinoma occurring in a patient 15 years after treatment for DES-associated vaginal clear cell adenocarcinoma. Hall WB; Detterbeck FC; Livasy CA; Fowler WC Gynecol Oncol; 2004 Jun; 93(3):708-10. PubMed ID: 15196869 [TBL] [Abstract][Full Text] [Related]
8. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma. Edelman DA Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761 [TBL] [Abstract][Full Text] [Related]
9. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero. Boyd J; Takahashi H; Waggoner SE; Jones LA; Hajek RA; Wharton JT; Liu FS; Fujino T; Barrett JC; McLachlan JA Cancer; 1996 Feb; 77(3):507-13. PubMed ID: 8630958 [TBL] [Abstract][Full Text] [Related]
10. [Diethylstilbestrol story]. Tournaire M; Epelboin S; Devouche E Therapie; 2014; 69(1):101-14. PubMed ID: 24698194 [TBL] [Abstract][Full Text] [Related]
11. Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain. Lin LM; Sciubba DM; Gallia GL; Sosnowski J; Weingart JD Gynecol Oncol; 2007 Apr; 105(1):273-6. PubMed ID: 17292458 [TBL] [Abstract][Full Text] [Related]
15. DES exposure: an update. Mittendorf R; Herbst AL Contemp Pediatr; 1994 Nov; 11(11):59-62, 64, 66 passim. PubMed ID: 10150281 [TBL] [Abstract][Full Text] [Related]
16. The current status of the DES-exposed population. Herbst AL Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873 [TBL] [Abstract][Full Text] [Related]
17. DES: a continuing health concern. Shaffer NG Pa Med; 2000 Mar; 103(3):17. PubMed ID: 10765641 [No Abstract] [Full Text] [Related]
18. Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero. Mittendorf R Teratology; 1995 Jun; 51(6):435-45. PubMed ID: 7502243 [TBL] [Abstract][Full Text] [Related]
19. [Administration of diethylstilbestrol during pregnancy, a public health problem]. Spira A; Goujard J; Henrion R; Lemerle J; Robel P; Tchobroutsky C Rev Epidemiol Sante Publique; 1983; 31(3):249-72. PubMed ID: 6361926 [TBL] [Abstract][Full Text] [Related]
20. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma. Waggoner SE; Mittendorf R; Biney N; Anderson D; Herbst AL Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]